The A-share digital and intelligent medical sector surged on the heels of new policy initiatives, heralding a wave of development opportunities for the digitization and intelligent transformation of the pharmaceutical industry. Seven departments, led by the Ministry of Industry and Information Technology, jointly unveiled a plan aimed at bolstering the application of artificial intelligence in healthcare and accelerating the smart upgradation of the entire industry chain. Projections suggest that by 2025, the digital healthcare market will expand beyond 1.8 trillion yuan, with AI-driven pharmaceuticals, smart factories, and precision medicine emerging as pivotal areas of focus. Securities analysts posit that AI technology stands to significantly enhance medical efficiency and corporate competitiveness, thereby catalyzing cost reductions and efficiency gains across the industry.